In April of this year, Biostone were delighted to find out that they had received US FDA 510K clearance for their first bone graft product, si-Mochi.

This follows Biostone being certified ISO13485:2016 by BSI in February.

Biostone are currently in the process of gaining the CE mark MDR certification.